Showing results 1 to 20 of 132
next >
| Preview | Issue Date | Title | Author(s) |
| 2011 | A preclinical study of stem subsidence and graft incorporation after femoral impaction grafting using porous hydroxyapatite as a bone graft extender | Howie, D.; Mc Gee, M.; Callary, S.; Carbone, A.; Stamenkov, R.; Bruce, W.; Findlay, D. |
| 1996 | A Type 1 collagen substrate increases PTH/PTHrP receptor MRNA expression and suppresses PTHrP mRNA expression in UMR106-06 osteoblast -like cells | Celic, S.; Chilco, P.; Zajac, J.; Martin, T.; Findlay, D. |
| 2014 | Analysis of vitamin D metabolism gene expression in human bone: evidence for autocrine control of bone remodelling | Ormsby, R.; Findlay, D.; Kogawa, M.; Anderson, P.; Morris, H.; Atkins, G.; Bikle, D.; Norman, A.; Welsh, J.; 16th Vitamin D Workshop (11 Jun 2013 - 14 Jun 2013 : San Francisco, CA, USA) |
| 2011 | Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo | Zinonos, I.; Labrinidis, A.; Lee, M.; Liapis, V.; Hay, S.; Ponomarev, V.; Diamond, P.; Findlay, D.; Zannettino, A.; Evdokiou, A. |
| 2009 | Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myeloma | Labrinidis, A.; Diamond, P.; Martin, S.; Hay, S.; Liapis, V.; Zinonos, I.; Sims, N.; Atkins, G.; Vincent, C.; Ponomarev, V.; Findlay, D.; Zannettino, A.; Evdokiou, A. |
| 2009 | Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer | Zinonos, I.; Labrinidis, A.; Lee, M.; Liapis, V.; Hay, S.; Ponomarev, V.; Diamond, P.; Zannettino, A.; Findlay, D.; Evdokiou, A. |
| 1999 | Bidirectional signaling between stromal and hemopoietic cells regulates interleukin-1 expression during human osteoclast formation | Haynes, D.; Atkins, G.; Loric, M.; Crotti, T.; Geary, S.; Findlay, D. |
| 2012 | Biocompatible polymer coating of titania nanotube arrays for improved drug elution and osteoblast adhesion | Gulati, K.; Ramakrishnan, S.; Aw, M.; Atkins, G.; Findlay, D.; Losic, D. |
| 2007 | Bone | Findlay, D. |
| 1997 | Bone Biology | Ng, K.; Romas, E.; Donnan, L.; Findlay, D. |
| 2018 | Bone matrix microdamage and vascular changes characterize bone marrow lesions in the subchondral bone of knee osteoarthritis | Muratovic, D.; Findlay, D.; Cicuttini, F.; Wluka, A.; Lee, Y.-R.; Kuliwaba, J. |
| 2006 | Bone resorption | Findlay, D.; Haynes, D. |
| 2018 | Both ligand and VDR expression levels critically determine the effect of 1α,25-dihydroxyvitamin-D₃ on osteoblast differentiation | Yang, D.; Anderson, P.; Wijenayaka, A.; Barratt, K.; Triliana, R.; Stapledon, C.; Zhou, H.; Findlay, D.; Morris, H.; Atkins, G. |
| 1996 | c-fos Antisense DNA Inhibits Proliferation of Osteoclast Progenitors in Osteoclast Developments but not Macrophage Differentiation In Vitro | Udagawa, N.; Chan, J.; Wada, S.; Findlay, D. |
| 2005 | Calcitonin | Findlay, D.; Sexton, P.; Martin, T.; De Groot, L.; Jameson, J. |
| 2003 | Calcitonin | Findlay, D.; Sexton, P.; Henry, H.; Norman, A.W. |
| 2004 | Calcitonin | Findlay, D.; Sexton, P. |
| 1998 | Calcitonin and its related proteins | Findlay, D. |
| 2002 | Calcitonin decreases the adherence and survival of HEK-293 cells by a caspase-independent mechanism | Findlay, D.; Raggatt, L.; Bouralexis, S.; Hay, S.; Atkins, G.; Evdokiou, A. |
| 1996 | Calcitonin Receptor Down-Regulation Relates to Calcitonin Resistance in Mature Mouse Osteoclasts | Wada, S.; Udagawa, N.; Nagata, N.; Martin, T.; Findlay, D. |
